CN108497277A - 复合果蔬抗癌营养餐配方 - Google Patents
复合果蔬抗癌营养餐配方 Download PDFInfo
- Publication number
- CN108497277A CN108497277A CN201810080153.XA CN201810080153A CN108497277A CN 108497277 A CN108497277 A CN 108497277A CN 201810080153 A CN201810080153 A CN 201810080153A CN 108497277 A CN108497277 A CN 108497277A
- Authority
- CN
- China
- Prior art keywords
- parts
- juice
- powder
- fruit
- nutritious food
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 20
- 230000001093 anti-cancer Effects 0.000 title claims abstract description 18
- 235000012054 meals Nutrition 0.000 title claims abstract description 17
- 150000001875 compounds Chemical class 0.000 title claims abstract description 16
- 235000012055 fruits and vegetables Nutrition 0.000 title claims abstract description 14
- 239000000843 powder Substances 0.000 claims abstract description 56
- 206010028980 Neoplasm Diseases 0.000 claims abstract description 48
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims abstract description 48
- 201000011510 cancer Diseases 0.000 claims abstract description 40
- 235000013305 food Nutrition 0.000 claims abstract description 40
- 235000008935 nutritious Nutrition 0.000 claims abstract description 32
- 235000020234 walnut Nutrition 0.000 claims abstract description 26
- 240000007049 Juglans regia Species 0.000 claims abstract description 25
- 235000009496 Juglans regia Nutrition 0.000 claims abstract description 25
- 235000005979 Citrus limon Nutrition 0.000 claims abstract description 22
- 244000131522 Citrus pyriformis Species 0.000 claims abstract description 22
- 240000002853 Nelumbo nucifera Species 0.000 claims abstract description 22
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims abstract description 22
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims abstract description 22
- 239000000463 material Substances 0.000 claims abstract description 22
- 235000005340 Asparagus officinalis Nutrition 0.000 claims abstract description 21
- 235000009419 Fagopyrum esculentum Nutrition 0.000 claims abstract description 21
- 244000298697 Actinidia deliciosa Species 0.000 claims abstract description 19
- 235000009436 Actinidia deliciosa Nutrition 0.000 claims abstract description 19
- JDLKFOPOAOFWQN-VIFPVBQESA-N Allicin Natural products C=CCS[S@](=O)CC=C JDLKFOPOAOFWQN-VIFPVBQESA-N 0.000 claims abstract description 19
- 244000003416 Asparagus officinalis Species 0.000 claims abstract description 19
- 235000010081 allicin Nutrition 0.000 claims abstract description 19
- JDLKFOPOAOFWQN-UHFFFAOYSA-N allicin Chemical compound C=CCSS(=O)CC=C JDLKFOPOAOFWQN-UHFFFAOYSA-N 0.000 claims abstract description 19
- 244000241838 Lycium barbarum Species 0.000 claims abstract description 17
- 235000015459 Lycium barbarum Nutrition 0.000 claims abstract description 17
- 235000013336 milk Nutrition 0.000 claims abstract description 17
- 239000008267 milk Substances 0.000 claims abstract description 17
- 210000004080 milk Anatomy 0.000 claims abstract description 17
- 210000000582 semen Anatomy 0.000 claims abstract description 17
- 235000013312 flour Nutrition 0.000 claims abstract description 16
- 235000015190 carrot juice Nutrition 0.000 claims abstract description 10
- 235000020384 spinach juice Nutrition 0.000 claims abstract description 10
- 235000015193 tomato juice Nutrition 0.000 claims abstract description 10
- 235000019987 cider Nutrition 0.000 claims abstract description 9
- 230000003340 mental effect Effects 0.000 claims abstract description 8
- 240000008620 Fagopyrum esculentum Species 0.000 claims abstract description 5
- 235000011430 Malus pumila Nutrition 0.000 claims description 16
- 235000015103 Malus silvestris Nutrition 0.000 claims description 16
- 235000007688 Lycopersicon esculentum Nutrition 0.000 claims description 14
- 240000003768 Solanum lycopersicum Species 0.000 claims description 14
- 235000002767 Daucus carota Nutrition 0.000 claims description 11
- 244000000626 Daucus carota Species 0.000 claims description 11
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims description 10
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims description 10
- 235000009685 Crataegus X maligna Nutrition 0.000 claims description 10
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims description 10
- 235000009486 Crataegus bullatus Nutrition 0.000 claims description 10
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims description 10
- 235000009682 Crataegus limnophila Nutrition 0.000 claims description 10
- 240000000171 Crataegus monogyna Species 0.000 claims description 10
- 235000004423 Crataegus monogyna Nutrition 0.000 claims description 10
- 235000002313 Crataegus paludosa Nutrition 0.000 claims description 10
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims description 10
- 235000009337 Spinacia oleracea Nutrition 0.000 claims description 10
- 235000009434 Actinidia chinensis Nutrition 0.000 claims description 9
- 235000021028 berry Nutrition 0.000 claims description 9
- 241000220225 Malus Species 0.000 claims description 7
- 235000015203 fruit juice Nutrition 0.000 claims description 7
- 238000002360 preparation method Methods 0.000 claims description 7
- 244000300264 Spinacia oleracea Species 0.000 claims description 2
- 230000035764 nutrition Effects 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 16
- 239000008280 blood Substances 0.000 abstract description 12
- 210000004369 blood Anatomy 0.000 abstract description 12
- 210000003734 kidney Anatomy 0.000 abstract description 9
- 235000019789 appetite Nutrition 0.000 abstract description 7
- 230000036528 appetite Effects 0.000 abstract description 7
- 235000005911 diet Nutrition 0.000 abstract description 6
- 230000037213 diet Effects 0.000 abstract description 6
- 235000021266 loss of appetite Nutrition 0.000 abstract description 6
- 238000005728 strengthening Methods 0.000 abstract description 6
- 238000009792 diffusion process Methods 0.000 abstract description 4
- 206010027476 Metastases Diseases 0.000 abstract description 3
- 230000009401 metastasis Effects 0.000 abstract description 3
- 235000015097 nutrients Nutrition 0.000 abstract description 3
- 238000002560 therapeutic procedure Methods 0.000 abstract description 3
- 208000019505 Deglutition disease Diseases 0.000 abstract description 2
- 241000219051 Fagopyrum Species 0.000 description 16
- 210000002784 stomach Anatomy 0.000 description 13
- 239000000796 flavoring agent Substances 0.000 description 12
- 235000019634 flavors Nutrition 0.000 description 12
- 210000004027 cell Anatomy 0.000 description 11
- 235000009508 confectionery Nutrition 0.000 description 11
- 210000000952 spleen Anatomy 0.000 description 10
- 239000003814 drug Substances 0.000 description 9
- 241000219315 Spinacia Species 0.000 description 8
- 235000013399 edible fruits Nutrition 0.000 description 8
- 230000029087 digestion Effects 0.000 description 7
- 206010010774 Constipation Diseases 0.000 description 6
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 230000036541 health Effects 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- 230000035922 thirst Effects 0.000 description 6
- 240000002234 Allium sativum Species 0.000 description 5
- 206010011224 Cough Diseases 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 201000006549 dyspepsia Diseases 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 235000004611 garlic Nutrition 0.000 description 5
- 235000012907 honey Nutrition 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 238000010791 quenching Methods 0.000 description 5
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 208000032843 Hemorrhage Diseases 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- 230000003712 anti-aging effect Effects 0.000 description 4
- 230000004596 appetite loss Effects 0.000 description 4
- 230000000740 bleeding effect Effects 0.000 description 4
- 230000004438 eyesight Effects 0.000 description 4
- 208000019017 loss of appetite Diseases 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 230000001256 tonic effect Effects 0.000 description 4
- 239000000341 volatile oil Substances 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 229930014669 anthocyanidin Natural products 0.000 description 3
- 150000001452 anthocyanidin derivatives Chemical class 0.000 description 3
- 235000008758 anthocyanidins Nutrition 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 229930003944 flavone Natural products 0.000 description 3
- 235000011949 flavones Nutrition 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- 210000002429 large intestine Anatomy 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 230000001151 other effect Effects 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 210000004881 tumor cell Anatomy 0.000 description 3
- 239000011800 void material Substances 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 2
- 241000234427 Asparagus Species 0.000 description 2
- 206010006187 Breast cancer Diseases 0.000 description 2
- 208000026310 Breast neoplasm Diseases 0.000 description 2
- 244000077995 Coix lacryma jobi Species 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 206010019345 Heat stroke Diseases 0.000 description 2
- 206010021118 Hypotonia Diseases 0.000 description 2
- 241000169546 Lycium ruthenicum Species 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 240000005809 Prunus persica Species 0.000 description 2
- 235000006040 Prunus persica var persica Nutrition 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 229930003451 Vitamin B1 Natural products 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000001088 anti-asthma Effects 0.000 description 2
- 239000000924 antiasthmatic agent Substances 0.000 description 2
- 230000036506 anxiety Effects 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 208000034158 bleeding Diseases 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 238000002512 chemotherapy Methods 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000001079 digestive effect Effects 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 208000017561 flaccidity Diseases 0.000 description 2
- 150000002213 flavones Chemical class 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- -1 green element Substances 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 210000003141 lower extremity Anatomy 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 239000002398 materia medica Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000007958 sleep Effects 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 229960003495 thiamine Drugs 0.000 description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 2
- 150000003648 triterpenes Chemical class 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 235000010374 vitamin B1 Nutrition 0.000 description 2
- 239000011691 vitamin B1 Substances 0.000 description 2
- 230000003442 weekly effect Effects 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 241000219068 Actinidia Species 0.000 description 1
- 244000298800 Actinidia arguta Species 0.000 description 1
- 235000016416 Actinidia arguta Nutrition 0.000 description 1
- 206010001497 Agitation Diseases 0.000 description 1
- 208000008710 Amebic Dysentery Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010001986 Amoebic dysentery Diseases 0.000 description 1
- 241001465677 Ancylostomatoidea Species 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 206010007027 Calculus urinary Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 208000017897 Carcinoma of esophagus Diseases 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 235000007354 Coix lacryma jobi Nutrition 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010012434 Dermatitis allergic Diseases 0.000 description 1
- 235000011511 Diospyros Nutrition 0.000 description 1
- 244000236655 Diospyros kaki Species 0.000 description 1
- 244000022372 Diospyros lotus Species 0.000 description 1
- 235000003333 Diospyros lotus Nutrition 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 208000000461 Esophageal Neoplasms Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 102100031416 Gastric triacylglycerol lipase Human genes 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 241000758791 Juglandaceae Species 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 201000009906 Meningitis Diseases 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 208000002454 Nasopharyngeal Carcinoma Diseases 0.000 description 1
- 206010061306 Nasopharyngeal cancer Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010053159 Organ failure Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 241000593989 Scardinius erythrophthalmus Species 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 208000001871 Tachycardia Diseases 0.000 description 1
- 241000224527 Trichomonas vaginalis Species 0.000 description 1
- 102000001742 Tumor Suppressor Proteins Human genes 0.000 description 1
- 108010040002 Tumor Suppressor Proteins Proteins 0.000 description 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 206010047623 Vitamin C deficiency Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 230000000118 anti-neoplastic effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000004531 blood pressure lowering effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 230000009084 cardiovascular function Effects 0.000 description 1
- 230000022131 cell cycle Effects 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 208000013507 chronic prostatitis Diseases 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000004320 controlled atmosphere Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000035613 defoliation Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- PCHPORCSPXIHLZ-UHFFFAOYSA-N diphenhydramine hydrochloride Chemical compound [Cl-].C=1C=CC=CC=1C(OCC[NH+](C)C)C1=CC=CC=C1 PCHPORCSPXIHLZ-UHFFFAOYSA-N 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 206010014881 enterobiasis Diseases 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 108010091264 gastric triacylglycerol lipase Proteins 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Natural products OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000001524 infective effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000013016 learning Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000002366 lipolytic effect Effects 0.000 description 1
- MUMCCPUVOAUBAN-UHFFFAOYSA-N liriodenine Chemical compound C1=NC(C(=O)C=2C3=CC=CC=2)=C2C3=C(OCO3)C3=CC2=C1 MUMCCPUVOAUBAN-UHFFFAOYSA-N 0.000 description 1
- FVRABHGHBLRNNR-UHFFFAOYSA-N liriodenine Natural products O=C1C=CC=c2c1cc3nccc4cc5OCOc5c2c34 FVRABHGHBLRNNR-UHFFFAOYSA-N 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 210000005075 mammary gland Anatomy 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 235000021281 monounsaturated fatty acids Nutrition 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 230000021332 multicellular organism growth Effects 0.000 description 1
- 201000011216 nasopharynx carcinoma Diseases 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000003950 pathogenic mechanism Effects 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 201000007094 prostatitis Diseases 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 239000001054 red pigment Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 208000010233 scurvy Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 210000000697 sensory organ Anatomy 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 150000005856 steroid saponins Chemical class 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000006794 tachycardia Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 230000005760 tumorsuppression Effects 0.000 description 1
- 208000008281 urolithiasis Diseases 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/09—Mashed or comminuted products, e.g. pulp, purée, sauce, or products made therefrom, e.g. snacks
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/198—Dry unshaped finely divided cereal products, not provided for in groups A23L7/117 - A23L7/196 and A23L29/00, e.g. meal, flour, powder, dried cereal creams or extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
本发明属于食疗营养餐领域,提供一种复合果蔬抗癌营养餐配方。针对癌症患者的特殊心理和身体特征,营养餐重量份配比:番茄汁50‑100份、胡萝卜汁50‑100份、芦笋汁30‑50份、菠菜汁50‑100份、苹果汁50‑100份、猕猴桃汁50‑100份、山楂汁20‑30份、柠檬汁20‑30份、莲子50‑100份、薏米30‑50份、核桃50‑70份、枸杞50‑70份、荞麦100‑150份、大蒜素粉20‑30份、奶粉50‑100份、精面粉等辅料适量。本发明提高癌症患者的食欲,进补营养元素的同时抑制癌细胞扩散。针对没胃口、不思饮食、吞咽困难的患者,只需进食少量本发明营养餐就可以满足身体最低能量需要;2、食用本发明达到一定的量时还可以起到抑制癌细胞转移等辅助作用;3、长期服用具有补血、补肾、强壮身体之功效。
Description
技术领域
本发明属于一种食疗营养餐配方,具体涉及一种复合果蔬抗癌营养餐配方。
背景技术
癌症是一大类恶性肿瘤的统称。癌细胞的特点是无限制、无止境地增生,使患者体内的营养物质被大量消耗;癌细胞释放出多种毒素,使人体产生一系列症状;癌细胞还可转移到全身各处生长繁殖,导致人体消瘦、无力、贫血、食欲不振、发热以及严重的脏器功能受损等等。与之相对的有良性肿瘤,良性肿瘤则容易清除干净,一般不转移、不复发,对器官、组织只有挤压和阻塞作用,但癌症(恶性肿瘤)还可破坏组织、器官的结构和功能,引起坏死出血合并感染,患者最终由于器官功能衰竭而死亡。
近年来,肿瘤发病率和死亡率逐年上升,严重威胁人类健康,已成为人类死亡的主要原因之一。目前,西医不能手术的肿瘤多是以化疗和放疗为主,但是,抗肿瘤化疗药物以及放疗都有严重的副反应,容易引起骨髓造血障碍、胃肠道反应以及原发性二次肿瘤等。
癌症患者在获悉自己病情的情况下,内心的恐惧与焦虑,严重影响睡眠、食欲减退、消化不良、免疫力急速下降、身体每况愈下,引发并发症,期间很少有患者能抱着积极的心态配合手术、放化疗治疗。
这种情况下,癌症患者心情焦虑,食欲大幅下降,无法通过饮食获得有效的营养元素,此外,长期的服药过程中,癌症患者的心理负担及逆反心理严重,病痛无法得到有效的缓解。
发明内容
本发明针对上述技术问题,提供复合果蔬抗癌营养餐配方,提高癌症患者的食欲,进补营养元素的同时抑制癌细胞扩散。
为达到上述目的,本发明具体采用如下技术方案:
复合果蔬抗癌营养餐配方,针对癌症患者的特殊心理和身体特征,营养餐重量份配比:番茄汁50-100份、胡萝卜汁50-100份、芦笋汁30-50份、菠菜汁50-100份、苹果汁50-100份、猕猴桃汁50-100份、山楂汁20-30份、柠檬汁20-30份、莲子50-100份、薏米30-50份、核桃50-70份、枸杞50-70份、荞麦100-150份、大蒜素粉20-30份、奶粉50-100份、精面粉等辅料适量。
所述营养餐制法为:将番茄、胡萝卜、芦笋、菠菜、苹果、猕猴桃、山楂、柠檬分别榨汁备用;莲子、薏米、核桃、枸杞、荞麦粉碎成细粉备用;再将大蒜素粉、奶粉、上述备用果汁、上述备用细粉及精面粉等辅料适量混合均匀成淤泥状,放至烘箱烘干,然后再粉碎成细粉,包装成营养餐包则得,该营养餐包冲水溶解即食。
优选的,复合果蔬抗癌营养餐配方,营养餐重量份配比:番茄汁75份、胡萝卜汁75份、芦笋汁40份、菠菜汁75份、苹果汁75份、猕猴桃汁75份、山楂汁25份、柠檬汁25份、莲子75份、薏米40份、核桃60份、枸杞60份、荞麦125份、大蒜素粉25份、奶粉75份、精面粉等辅料适量。
本发明配方功效及理论依据:
番茄,番茄性微寒,味甘酸。具有生津止渴、健胃消食、清热解毒。对热性病口渴、过食油腻厚味所致的消化不良、中暑、胃热口苦、虚火上炎等病症有较好的治疗效果。
番茄含有大量的维生素C,有助于满足癌症患者对维生素C的需求。它还富含番茄红素,能防止、破坏前列腺内的氧化反应。研究发现,每周吃4次配合有番茄的膳食,患前列腺癌的风险可降低20%,每周吃8次配有番茄的膳食,则可降低50%。
西红柿的食疗价值:可治真菌、感染性皮肤病;美容、防衰老;具有较强的清热解毒、抑制病变功效,起到防癌和辅助治疗癌症的作用;降血压效果明显;治贫血、溃疡、肝炎;防中暑、退高烧、牙龈出血等。
胡萝卜,胡萝卜富含糖类、脂肪、挥发油、胡萝卜素、维生素A、维生素B1、维生素B2、花青素、钙、铁等营养成分。中医认为,胡萝卜味甘、性平,无毒,入肺、脾经。具有健脾消食,润肠通便,杀虫,行气化滞,补肝明目,清热解毒等功效;能治疗食欲不振、腹胀、腹泻、咳喘痰多、视物不明、小儿营养不良、麻疹、夜盲症、便秘、高血压、肠胃不适、饱闷气胀等。《本草求真》:“胡萝卜,因味辛则散,味甘则和,质重则降。故能宽中下气,而使肠胃之邪,与之俱去也。但书又言补中健食,非是中虚得此则补,中虚不食得此则健,实因邪去而中受其补益之谓耳。”《医林纂要》:“润肾命,壮元阳,暖下部,除寒湿。”
柠檬,柠檬味酸甘、性平,入肝、胃经;柠檬中含有糖类、钙、磷、铁及维生素B1、B2、C等多种营养成分,此外,还有丰富的柠檬酸和黄酮类、挥发油、橙皮甙等。柠檬酸具有防止和消除皮肤色素沉着的作用。中医认为:柠檬是一种营养和药用价值都极高的水果,它具有很强的抗氧化作用,对促进肌肤的新陈代谢、延缓衰老及抑制色素沉淀都十分有效。不仅如此,柠檬还具有生津止渴、和胃降逆、化痰止咳的功效。
苹果,味甘、酸;性凉;无毒。苹果,又名柰、频婆、天然子,有“智慧果”、“记忆果”的美称。有的科学家和医师把苹果称为“全方位的健康水果”或“全科医生”。苹果中含有黄酮类化合物。芬兰的研究工作者1999年10月发表的一项研究报告表明——苹果中所含的黄酮类化合物是降低癌症发病率的有效物质。每天吃苹果1个以上可以使结肠直肠癌、食道癌、喉癌、乳腺癌和卵巢癌等癌症发生危险降低9%~42%。最近国外一项研究发现,苹果的好处又新增了一项,那就是长期食用可治疗男性的慢性前列腺炎。
猕猴桃,猕猴桃为猕猴桃科猕猴桃属多年生落叶藤本植物,在我国东北三省的分布最为广泛.其果实、根、茎叶均可入药,具有抗肿瘤、抗辐射、提高免疫功能等药理活性.研究表明,软枣猕猴桃全株含有挥发油、三萜、黄酮、多糖等化学成分.综述了近年来从软枣猕猴桃果实、根、茎叶中分离到的挥发油类、三萜类、黄酮类等化学成分,及其肿瘤抑制、抗辐射、提高免疫功能、抗衰老、治疗过敏性皮炎、抗哮喘等药理活性,为进一步开发利用该药用植物资源提供理论依据。
菠菜,菠菜味甘、性凉,入大肠、胃经。可补血止血,利五脏,通肠胃,调中气,活血脉,止渴润肠,敛阴润燥,滋阴平肝,助消化;主治高血压、头痛、目眩、风火赤眼、糖尿病、便秘、消化不良、跌打损伤、衄血、便血、坏血病、大便涩滞。芦笋性寒、味甘苦,有健脾益气、滋阴润燥、生津解渴、化痰止咳的功效。《本草纲目》中认为,食用菠菜可以“通血脉,开胸膈,下气调中,止渴润燥”。古代阿拉伯人也称它为“蔬菜之王”。
芦笋是一种药食兼宜的蔬菜,含有丰富的糖类、蛋白质及多种维生素,天门冬酰胺和多种甾体皂苷、叶酸、甘露聚酯作为芦笋中特殊的营养成分,对防治各种癌症均有一定效果。食用芦笋还可消除疲劳、增强体质,对心脏病、高血压、心率过速、水肿、肠胃病等也有一定辅助疗效。
大蒜,大蒜味辛,性温。入脾、胃、肺经。具有健胃,止痢,止咳,杀菌,驱虫。预防流行性感冒、流行性脑脊髓膜炎。治肺结核,百日咳,食欲不振,消化不良,细菌性痢疾,阿米巴痢疾,肠炎,蛲虫病,钩虫病;外用治阴道滴虫,急性阑尾炎。大蒜是很好的营养品,它的营养价值高于人参,位列保健品之首;除含有较多的蛋白质、糖及维生素c和钙、铁等无机盐外,还有很强的杀菌能力。因此,大蒜除了是调味品、能助消化、增食欲外,又是防病治病的良药。《名医别录》:“散痈肿魇疮,除风邪,杀毒气”。《随息居饮食谱》:“生者辛热,熟者甘温,除寒湿,辟阴邪,下气暖中,消谷化肉,破恶血,攻冷积。治暴泻腹痛,通关格便秘,辟秽解毒,消痞杀虫。外灸痈疽,行水止衄”。大蒜素又称“抗癌之王”,它可以降低某些肿瘤的患病率。试验证明,大蒜素不仅能抑制致癌物的致癌作用,而且对肿瘤细胞的增殖也有抑制作用。大蒜素的抑癌机制有:抗氧化;影响肿瘤细胞的细胞周期并诱导肿瘤细胞凋亡;是一种较好的免疫激发性物质;对抗肿瘤药物有增敏作用等。
核桃,核桃味甘、性温,入肾、肺、大肠经;具有补肾、固精强腰、温肺定喘、润肠通便。主治肾虚喘嗽、腰痛脚弱、阳痿遗精、小便频数、石淋、大便燥结。促进葡萄糖利用、胆固醇代谢和保护心血管的功能。镇咳平喘,冬季,对慢性气管炎和哮喘病患者疗效极佳。可见经常食用核桃,既能健身体,又能抗衰老。有些人往往吃补药,其实每天早晚各吃几枚核桃,实在大有裨益,往往比吃补药还好。我国传统中药学有“药食同源”理论,强调“药补不如食补”,而核桃正具“药食同源”之特性,具有“健脑益智、养颜延寿”之功效;《神农本草经》将核桃列为久服可轻身益气、延年益寿的上品,《开宝本草》曰:核桃仁“食之令人肥健、润肌、黑须发”,《本草纲目》称核桃仁“补气养血,润燥化痰,益命门,利三健,温肺润肠”,唐代名医孟洗说核桃仁“通经脉,润血脉,常服骨肉细腻光润”。由于核桃中含丰富的单不饱和脂肪酸与多不饱和脂肪酸,其中多不饱和脂肪酸中的ω-3脂肪酸能降低癌肿从血液中提取的亚油酸的数量,使癌肿戒除了一种非常需要的营养物质。
薏苡仁(俗称“米仁”):性凉、味甘、淡,有利水渗湿、健脾止泻。米仁中含有的薏苡仁酯,是有效的抗癌成分,有助于防治胃癌、子宫颈癌。癌症患者适当多吃米仁有祛癌毒,缓解放化疗的毒副作用,可减少腹水,改善消化吸收功能。
黑枸杞,黑枸杞具有补肾益精、护肝明目、增进视力、美容养颜、改善皮肤、清热解火,滋补肝肾,补气血,健脾胃,杀死癌细胞,预防癌细胞转移等功效。主治心热病、心脏病、月经不调、停经等。黑果枸杞中具有花青素类天然色素成分,花青素清除自由基的功效,亦可让癌细胞无法顺利扩散,借此保护更多健康的细胞免于被癌细胞侵蚀。另一方面有些癌症透过溶解组织和细胞的物质形成肿瘤,这些癌细胞产生溶解脢和蛋白脢,而花青素能保护蛋白质不受蛋白脢的影响。像是乳腺癌的致病机制便是如此,因此服用花青素对于乳腺癌的发展会有很好的抑制作用。
荞麦,荞麦性平、味甘凉,归胃、大肠经。具有健脾益气,开胃宽肠,消食化滞,除湿下气等功效。荞麦中含有大量的镁,镁不但能抑制癌症的发展,还可帮助血管舒张,维持心肌正常功能,加强肠道蠕动,增加胆汁,促进机体排除废物。荞麦中还含有一种抗癌因子——谷胱甘肽。
莲子:莲子性平、味甘涩,入心、脾、肾经;具有补脾止泻,益肾涩清,养心安神。用于脾虚久泻,遗精带下,心悸失眠。主治夜寐多梦,失眠,健忘,心烦口渴,腰痛脚弱,耳目不聪,遗精,淋浊,久痢,虚泻,妇女崩漏带下以及胃虚不欲饮食等病症。莲子善于补五脏不足,通利十二经脉气血,使气血畅而不腐,莲子所含氧化黄心树宁碱对鼻咽癌有抑制作用,这一切,构成了莲子的防癌抗癌的营养保健功能。
山楂,山楂具有消食积、化滞瘀。主治:饮食积滞、脘腹胀痛、泄泻痢疾、血瘀痛经、闭经、产后腹痛、恶露不尽。山楂含Vc、VB2、胡萝卜素及多种有机酸,口服能增加胃中消化酶的分泌,并能增强酶的活性,促进消化,其中所含的解脂酶能直接帮助消化脂肪类食物,且能加强胃脂肪酶、蛋白酶的活性。
本发明所达到有益效果:提高癌症患者的食欲,进补营养元素的同时抑制癌细胞扩散。1、针对没胃口、不思饮食、吞咽困难的患者,只需进食少量本发明营养餐就可以满足身体最低能量需要;2、食用本发明达到一定的量时还可以起到抑制癌细胞转移等辅助作用;3、长期服用具有补血、补肾、强壮身体之功效。
具体实施方式
下面将结合本发明实施例,对本发明的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。
下面对发明专利实例中的技术方案进行清楚,完整的描述,当然,所描述的实施例仅仅是本发明一部份实施例,而不是全部的实施例。基于本发明中实施例,本领域普通技术人员没有作出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护范围。
实施例1
复合果蔬抗癌营养餐配方,针对癌症患者的特殊心理和身体特征,营养餐重量份配比:番茄汁75份、胡萝卜汁75份、芦笋汁40份、菠菜汁75份、苹果汁75份、猕猴桃汁75份、山楂汁25份、柠檬汁25份、莲子75份、薏米40份、核桃60份、枸杞60份、荞麦125份、大蒜素粉25份、奶粉75份、精面粉等辅料适量。辅料可采用适量蜂蜜,看混合后浓度状况。
所述营养餐制法为:将番茄、胡萝卜、芦笋、菠菜、苹果、猕猴桃、山楂、柠檬分别榨汁备用;莲子、薏米、核桃、枸杞、荞麦粉碎成细粉备用;再将大蒜素粉、奶粉、上述备用果汁、上述备用细粉及精面粉等辅料适量混合均匀成淤泥状,放至烘箱烘干,然后再粉碎成细粉,包装成营养餐包则得,该营养餐包冲水溶解即食。
实施例2
复合果蔬抗癌营养餐配方,针对癌症患者的特殊心理和身体特征,营养餐重量份配比:番茄汁50份、胡萝卜汁100份、芦笋汁30份、菠菜汁100份、苹果汁50份、猕猴桃汁100份、山楂汁20份、柠檬汁30份、莲子50份、薏米50份、核桃50份、枸杞70份、荞麦100份、大蒜素粉30份、奶粉50份、精面粉等辅料适量。辅料可采用适量蜂蜜,看混合后浓度状况。
所述营养餐制法为:将番茄、胡萝卜、芦笋、菠菜、苹果、猕猴桃、山楂、柠檬分别榨汁备用;莲子、薏米、核桃、枸杞、荞麦粉碎成细粉备用;再将大蒜素粉、奶粉、上述备用果汁、上述备用细粉及精面粉等辅料适量混合均匀成淤泥状,放至烘箱烘干,然后再粉碎成细粉,包装成营养餐包则得,该营养餐包冲水溶解即食。
实施例3
复合果蔬抗癌营养餐配方,针对癌症患者的特殊心理和身体特征,营养餐重量份配比:番茄汁100份、胡萝卜汁50份、芦笋汁50份、菠菜汁50份、苹果汁100份、猕猴桃汁50份、山楂汁30份、柠檬汁20份、莲子100份、薏米30份、核桃70份、枸杞50份、荞麦150份、大蒜素粉20份、奶粉100份、精面粉等辅料适量。辅料可采用适量蜂蜜,看混合后浓度状况。
所述营养餐制法为:将番茄、胡萝卜、芦笋、菠菜、苹果、猕猴桃、山楂、柠檬分别榨汁备用;莲子、薏米、核桃、枸杞、荞麦粉碎成细粉备用;再将大蒜素粉、奶粉、上述备用果汁、上述备用细粉及精面粉等辅料适量混合均匀成淤泥状,放至烘箱烘干,然后再粉碎成细粉,包装成营养餐包则得,该营养餐包冲水溶解即食。
实施例4
复合果蔬抗癌营养餐配方,针对癌症患者的特殊心理和身体特征,营养餐重量份配比:番茄汁50份、胡萝卜汁50份、芦笋汁30份、菠菜汁50份、苹果汁50份、猕猴桃汁50份、山楂汁20份、柠檬汁20份、莲子50份、薏米30份、核桃50份、枸杞50份、荞麦100份、大蒜素粉20份、奶粉50份、精面粉等辅料适量。辅料可采用适量蜂蜜,看混合后浓度状况。
所述营养餐制法为:将番茄、胡萝卜、芦笋、菠菜、苹果、猕猴桃、山楂、柠檬分别榨汁备用;莲子、薏米、核桃、枸杞、荞麦粉碎成细粉备用;再将大蒜素粉、奶粉、上述备用果汁、上述备用细粉及精面粉等辅料适量混合均匀成淤泥状,放至烘箱烘干,然后再粉碎成细粉,包装成营养餐包则得,该营养餐包冲水溶解即食。
实施例5
复合果蔬抗癌营养餐配方,针对癌症患者的特殊心理和身体特征,营养餐重量份配比:番茄汁100份、胡萝卜汁100份、芦笋汁50份、菠菜汁100份、苹果汁100份、猕猴桃汁100份、山楂汁30份、柠檬汁30份、莲子100份、薏米50份、核桃70份、枸杞70份、荞麦150份、大蒜素粉30份、奶粉100份、精面粉等辅料适量。辅料可采用适量蜂蜜,看混合后浓度状况。
所述营养餐制法为:将番茄、胡萝卜、芦笋、菠菜、苹果、猕猴桃、山楂、柠檬分别榨汁备用;莲子、薏米、核桃、枸杞、荞麦粉碎成细粉备用;再将大蒜素粉、奶粉、上述备用果汁、上述备用细粉及精面粉等辅料适量混合均匀成淤泥状,放至烘箱烘干,然后再粉碎成细粉,包装成营养餐包则得,该营养餐包冲水溶解即食。
尽管已经示出和描述了本发明的实施例,对于本领域的普通技术人员而言,可以理解在不脱离本发明的原理和精神的情况下可以对这些实施例进行多种变化、修改、替换和变型,本发明的范围由所附权利要求及其等同物限定。
Claims (2)
1.复合果蔬抗癌营养餐配方,其特征在于,针对癌症患者的特殊心理和身体特征,营养餐重量份配比:番茄汁50-100份、胡萝卜汁50-100份、芦笋汁30-50份、菠菜汁50-100份、苹果汁50-100份、猕猴桃汁50-100份、山楂汁20-30份、柠檬汁20-30份、莲子50-100份、薏米30-50份、核桃50-70份、枸杞50-70份、荞麦100-150份、大蒜素粉20-30份、奶粉50-100份、精面粉等辅料适量;
所述营养餐制法为:将番茄、胡萝卜、芦笋、菠菜、苹果、猕猴桃、山楂、柠檬分别榨汁备用;莲子、薏米、核桃、枸杞、荞麦粉碎成细粉备用;再将大蒜素粉、奶粉、上述备用果汁、上述备用细粉及精面粉等辅料适量混合均匀成淤泥状,放至烘箱烘干,然后再粉碎成细粉,包装成营养餐包则得,该营养餐包冲水溶解即食。
2.根据权利要求1所述的复合果蔬抗癌营养餐配方,其特征在于,营养餐重量份配比:番茄汁75份、胡萝卜汁75份、芦笋汁40份、菠菜汁75份、苹果汁75份、猕猴桃汁75份、山楂汁25份、柠檬汁25份、莲子75份、薏米40份、核桃60份、枸杞60份、荞麦125份、大蒜素粉25份、奶粉75份、精面粉等辅料适量。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810080153.XA CN108497277A (zh) | 2018-01-27 | 2018-01-27 | 复合果蔬抗癌营养餐配方 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810080153.XA CN108497277A (zh) | 2018-01-27 | 2018-01-27 | 复合果蔬抗癌营养餐配方 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108497277A true CN108497277A (zh) | 2018-09-07 |
Family
ID=63374596
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810080153.XA Pending CN108497277A (zh) | 2018-01-27 | 2018-01-27 | 复合果蔬抗癌营养餐配方 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108497277A (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109123031A (zh) * | 2018-09-11 | 2019-01-04 | 万光瑞 | 一种强身抗癌组合物及其制备方法 |
CN109730313A (zh) * | 2019-02-20 | 2019-05-10 | 深圳市淳睿贸易有限公司 | 辅助餐食组合物 |
CN113412943A (zh) * | 2021-06-17 | 2021-09-21 | 山东省食品发酵工业研究设计院 | 促进安全吞咽的营养食品及其制备方法 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102860460A (zh) * | 2012-10-17 | 2013-01-09 | 安徽燕之坊食品有限公司 | 一种具有防癌抗癌功效的杂粮果蔬食品及其制法 |
CN104605372A (zh) * | 2015-02-10 | 2015-05-13 | 王中卫 | 一种基于恶性肿瘤放疗患者的营养药膳及制备方法 |
CN104886707A (zh) * | 2015-05-11 | 2015-09-09 | 刘先国 | 果蔬复合代餐固体养生抗癌饮料及其制备方法 |
CN106036894A (zh) * | 2016-07-07 | 2016-10-26 | 广州诺金制药有限公司 | 一种改善癌症患者化疗症状的食品组合物及其制备方法 |
CN106509722A (zh) * | 2016-11-08 | 2017-03-22 | 安徽省纽斯康生物工程有限公司 | 一种预防肿瘤的营养果蔬粉及其制备方法 |
CN106722945A (zh) * | 2016-12-09 | 2017-05-31 | 谭淞文 | 一种速溶型抗癌代餐粉及其制备方法、使用方法 |
-
2018
- 2018-01-27 CN CN201810080153.XA patent/CN108497277A/zh active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102860460A (zh) * | 2012-10-17 | 2013-01-09 | 安徽燕之坊食品有限公司 | 一种具有防癌抗癌功效的杂粮果蔬食品及其制法 |
CN104605372A (zh) * | 2015-02-10 | 2015-05-13 | 王中卫 | 一种基于恶性肿瘤放疗患者的营养药膳及制备方法 |
CN104886707A (zh) * | 2015-05-11 | 2015-09-09 | 刘先国 | 果蔬复合代餐固体养生抗癌饮料及其制备方法 |
CN106036894A (zh) * | 2016-07-07 | 2016-10-26 | 广州诺金制药有限公司 | 一种改善癌症患者化疗症状的食品组合物及其制备方法 |
CN106509722A (zh) * | 2016-11-08 | 2017-03-22 | 安徽省纽斯康生物工程有限公司 | 一种预防肿瘤的营养果蔬粉及其制备方法 |
CN106722945A (zh) * | 2016-12-09 | 2017-05-31 | 谭淞文 | 一种速溶型抗癌代餐粉及其制备方法、使用方法 |
Non-Patent Citations (1)
Title |
---|
毕金峰等: "国内外果蔬粉加工技术与产业现状及展望 ", 《中国食品学报》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109123031A (zh) * | 2018-09-11 | 2019-01-04 | 万光瑞 | 一种强身抗癌组合物及其制备方法 |
CN109730313A (zh) * | 2019-02-20 | 2019-05-10 | 深圳市淳睿贸易有限公司 | 辅助餐食组合物 |
CN113412943A (zh) * | 2021-06-17 | 2021-09-21 | 山东省食品发酵工业研究设计院 | 促进安全吞咽的营养食品及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101695376B (zh) | 预防糖尿病的保健食品 | |
CN107173694A (zh) | 一种营养全面平衡的全素食代餐粉配方 | |
CN106722963A (zh) | 一种素食餐 | |
CN109966417A (zh) | 一种针对糖尿病人群的固体饮料 | |
CN104873763A (zh) | 一种调理气虚体质的保健品 | |
CN104171985A (zh) | 一种均衡营养复合型芽苗健康食品 | |
CN107114663A (zh) | 一种果蔬养胃米粉及其制备方法 | |
CN108887564A (zh) | 一种硒蛋白杂粮粉配方及其制备方法 | |
CN105233100A (zh) | 一种治疗糖尿病的饮料及其制备方法 | |
CN107156828A (zh) | 一种适用于炎性肠病患者的全营养配方食品 | |
CN109588452A (zh) | 安全可靠营养均衡的滋补类蔬菜素食代餐饼干及其制作方法 | |
CN106937741A (zh) | 一种脱脂亚麻籽粉防癌抗癌健康减肥法及其制备方法 | |
CN108497277A (zh) | 复合果蔬抗癌营养餐配方 | |
CN103689559A (zh) | 一种有助于改善胃肠功能的养生保健食品配方及其制备方法 | |
CN103652926A (zh) | 肿瘤病人食品组合物 | |
CN108497474A (zh) | 一种全植物药食糊 | |
WO2022143466A1 (zh) | 一种预防癌症药食同源植物中药组合物 | |
CN104323391B (zh) | 一种植物保健固体饮料及其制备方法 | |
CN111184176A (zh) | 基于体质学说用于九种不同体质的速食型养生食品组合物 | |
CN110583974A (zh) | 一种瘦身全谷营养健康代餐食品及其制备方法 | |
CN110214902A (zh) | 一种儿童纠正偏食型富硒全营养粉 | |
CN104605372A (zh) | 一种基于恶性肿瘤放疗患者的营养药膳及制备方法 | |
CN103689561A (zh) | 一种有助于降脂减肥的养生保健食品配方及其制备方法 | |
CN106822660A (zh) | 一种治疗心脑血管疾病的中药制剂 | |
CN105617268A (zh) | 一种治疗鳞屑角化型脚气的药物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180907 |
|
RJ01 | Rejection of invention patent application after publication |